HR 6977
Independent Drug Value Assessment Act of 2024
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill establishes a demonstration project to create independent value assessments for drugs. The Department of Health and Human Services will contract with qualified organizations to analyze the benefits of new and previously approved drugs, considering patient impact and excluding companies involved in drug manufacturing or insurance. These assessments will be published publicly and aim to provide a more comprehensive understanding of drug value beyond traditional metrics, including potential price adjustments tied to the Consumer Price Index.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Katie Porter
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.